Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Efficacious E-Cigarette Interventions and Cessation Effects on Cancer-Related Biomarkers: A Randomized Trial of Varenicline in Adults

NCT07040566 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT07040566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07040566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Efficacious E-Cigarette Interventions and Cessation Effects on Cancer-Related Biomarkers: A Randomized Trial of Varenicline in Adults
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Recruiting
Start date
October 14, 2025
Completion date
October 30, 2030
Enrollment
326 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

e-cigarette use, nicotine dependence, vaping